PDCD1LG2 and neoplasm: Both B7-H3 and NT5E, along with a third immune checkpoint gene (PD-L2) are expressed at higher levels in C2 tumours (Supplementary Fig. 12) and hypomethylation of two CpGs in the NT5E promoter is evident in C2 tumours (Supplementary Data 5).